Tag Archives: Professional Marketing

Mapping Opportunities with the Non-Physician Prescriber

By Clark Herman | Published: April 5, 2013

They write 92% of their prescriptions without consulting a physician and are often the first provider a patient sees, and yet nurse practitioners, physician’s assistants and other non-physician prescribers (NPPs) are still somehow overlooked by pharma as an opportunity to drive sales. A GSW Worldwide report titled The non-physician prescriber will see you now points [...]

Posted in Advertising, Marketing, Patient Communication, Sales, Strategy, compliance, healthcare, patient compliance, patient education | Also tagged Aetna, GSW Worldwide, non-physician prescriber, nurse practitioner, physician's assistant, physicians, primary care physicians, professional sales, report, sales representatives, Sales Reps, Strategy | Leave a comment

ePharma Summit: Turning Big Data into Better Content

By Ben Comer | Published: March 6, 2013

Physicians and patients are more intimately engaged with their digital devices than ever before, but the content pharma delivers is either rigidly scientific or numbingly bland. Can stronger analytical processes and more data produce a scalable human voice for individual customers?

Posted in Advertising, E-Media, Events, FDA, Marketing, Patient Communication, Regulatory, Sales, Strategy, Technology, healthcare, multimedia, social media | Also tagged digital marketing, ePharma Summit, patient education, patient engagement | Leave a comment

US v. Caronia: What Constitutes 'Truthful' Speech?

By Ben Comer | Published: December 5, 2012

If a drug’s label is not the final word on what is true – or untrue – about a product, then who decides what can and cannot be said during a sales detail?

Posted in Advertising, FDA, Legal, Marketing, Regulatory, Safety, Sales, Strategy, compliance | Also tagged Alfred Caronia, Appeals Court, Detailing, DoJ, FDA, Federal Trade Commission, FTC, Jazz Pharmaceuticals, Marketing, off-label, Office of Prescription Drug Promotion, Orphan Medical, OTC, Promotion, Regulatory, sales rep, Sorrell v. IMS Health, US v. Caronia | 1 Comment

Diabetes Drug Launch 2012: Tip-tops and Promo-flops

By Clark Herman | Published: October 12, 2012

With Halloween candy flooding the shelves in pharmacies across the nation, it’s only appropriate that we turn the conversation toward an ever-growing drug market and therapeutic area: diabetes.

Posted in Advertising, E-Media, FDA, Marketing, Meetings, Strategy | Also tagged Amylin, Boehringer Ingelheim, Eli Lilly, Launch, Merck | 1 Comment

Advancing Pharma's Social Media Listening Analytics

By Ben Comer | Published: September 6, 2012

Big Pharma’s tin ear for social, user-generated content online is softening despite regulatory anxiety. In the quest to better understand what patients and doctors need, pharma – thanks in part to a bevy of third-party service providers – is beginning to recognize and incorporate insights from social media into their development and commercialization programs, according [...]

Posted in Advertising, Agency Insight, E-Media, Marketing, Regulatory, Sales, Strategy, Technology, social media | Also tagged Agency, Marketing, social media | 5 Comments